Shingles diagnoses are falling among younger US adults, a generation increasingly vaccinated against chickenpox as children, according to US electronic health records from more than 85 million patients. Between 2019 and 2026 rates dropped in every band under 35, among the first generations to grow up with routine childhood varicella vaccination.

The pattern is consistent with evidence that preventing wild-type varicella infection can also reduce the later risk of shingles, although the new data do not establish that relationship or show whether protection will persist into older age. ⁠

What Shingles Does to Nerves and Skin

Shingles, or herpes zoster, is reactivation of varicella-zoster virus, the herpesvirus that causes chickenpox. After primary infection the virus retreats into sensory ganglia and can stay latent for decades.

When immune control weakens, the virus can reactivate and travel along a sensory nerve to the skin, producing a unilateral blistering rash, usually on the trunk, after days of burning pain. The rash typically clears within two to four weeks. Postherpetic neuralgia, the most common complication, can leave nerve pain for months, and outbreaks near the eye risk vision loss.

The US Centers for Disease Control and Prevention estimates about one in three Americans will develop shingles, with roughly one million cases a year. Risk rises sharply after 50 and is higher when illness or medication suppresses immunity.

Read more

How Cases Are Dropping in Vaccinated Adults

Epic Research logged diagnoses from 2019 to 2026. Among women aged 30 to 34 the rate fell from 10.8 to 7.3 cases per 10,000; among men it fell from 11 to 7.3. In the 25-to-29 group it more than halved, from 7.7 to 3.2 per 10,000 women and from 7.5 to 3.0 per 10,000 men.

Rates among 18-to-24-year-olds moved from 2.9 to 1.6 per 10,000 women and from 2.7 to 2.4 per 10,000 men. 'Our data suggest that trend is now reversing in the very youngest adults, the first generation eligible to be vaccinated against chickenpox as children,' said Kersten Bartelt, lead author of the Epic report.

Shingles remains rare under 50, so the figures cannot show whether lower risk will hold with age. The decline was concentrated among younger adults, while the longer-term pattern in older age groups remains different. ⁠Surgeon Terry Simpson noted on X that claims of a vaccine-driven epidemic do not match the record.

Why the Chickenpox Vaccine Changes the Equation

The FDA licensed the first US varicella vaccine in 1995, and routine childhood vaccination began the following year; the programme later expanded to a routine two-dose schedule. States began requiring it for school from 1997.

The CDC recommends two doses, with the first given at 12 to 15 months and the second at 4 to 6 years. Chickenpox cases have since fallen by more than 97 per cent.

In the early 1990s the virus infected more than four million people a year and killed 100 to 150. Over its first 25 years, the programme prevented an estimated 91 million cases and saved $23.4 billion in healthcare costs.

'People who have had the chickenpox virus have a higher risk of developing shingles,' said Dr Sharon Curhan of Brigham and Women's Hospital and Harvard Medical School. Vaccine-strain reactivation can still occur, yet studies show lower rates after vaccination than after wild infection. ⁠

Young-adult shingles cases are the first large-scale sign that the childhood chickenpox vaccine is reshaping herpes zoster as recipients enter their thirties. Later-life protection remains unproven, and shingles vaccines remain advised for older adults. For those under 35, early numbers are moving in one direction.

Read more